Justice committee  Thank you, Mr. Chairman, and thank you to the members of the Standing Committee on Justice and Human Rights for allowing me this opportunity to speak to you about Canada's national anti-drug strategy. This strategy represents Canada's approach to reducing the supply of and demand

Justice committee  I don't know percentage-wise, to be frank. I know raw numbers, so maybe I can go over those and we can figure them out together. For prevention, overall the government announced $232 million over five years for the national anti-drug strategy, of which $30 million is going to the

Justice committee  When you add in the treatment aspect, it's $30 million plus another $85.5 million. So again, I don't have my calculator here—I'm a generalist, not a mathematician—but in any event, you put those two amounts together and it's about $116 million or so.

Justice committee  You did say prevention and treatment, so I was responding in that regard.

Justice committee  It was 2007.

Justice committee  Numbers are dastardly little things. What I'm referring to are the Health Canada moneys only out of the $232 million. So it's $30 million for our prevention, $85.5 for the treatment action plan that Health Canada manages, and then we do have a small budget also that we contribute

Justice committee  Thank you for the question. As I mentioned, for our prevention activities under the national anti-drug strategy, we've targeted that $30 million for a campaign. We also have moneys within the department for the drug strategy community initiative fund, which does look at innovati

Justice committee  I'm going to ask my colleague Colleen Ryan to respond.

Justice committee  It's not our expertise either.

Health committee  I think you were very comprehensive. One minor comment is that under the federal tobacco control strategy, our partners in Public Safety, the RCMP and others receive funding to monitor the marketplace for contraband. They are in the best position to respond to that question.

Health committee  The menthol market in Canada is quite different, as Mr. Glover just said. Menthol has been in the marketplace since 1934, and retail sales in Canada have fallen over time. Between 2001 and 2007, unit sales of menthol have declined by 26%. So it's not the same as the market for l

Health committee  Yes. Thank you for the expanded question. It's very true that the Tobacco Act is really looking at the illicit market--the manufacture, the sale, and the industry practices, promotions, techniques, and so on. Both are equally critical, but this is dealing with only the one set o

Health committee  It's not the intent of the bill to interfere with information at retail. By removing the advertising described in paragraph 22(2)(b), we will no longer allow publications in Canada, as Mr. Glover was showing earlier. That's the intent; it's not to impact at the retail level. Th

Health committee  I would add to Mr. Glover's comments that the federal tobacco control strategy is built on four pillars, and they're interrelated. There's cessation, prevention, product regulation, and what we call protection, but basically it's second-hand smoke. This bill is very visé towards

Health committee  Yes, thank you, I'll start. The Tobacco Act was brought into force in 1997, and through that we were able to implement a number of regulatory measures, including the first-in-the-world health warning messages on packages. We work very closely and cooperatively with our PT partn